{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:33:36Z","timestamp":1761896016039},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,3,26]],"date-time":"2015-03-26T00:00:00Z","timestamp":1427328000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Diabetol"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1007\/s00592-015-0732-1","type":"journal-article","created":{"date-parts":[[2015,3,25]],"date-time":"2015-03-25T05:47:21Z","timestamp":1427262441000},"page":"35-40","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Identification of predictors of response to basal insulin and DPP4 inhibitors in patients with type 2 diabetes failing to other therapies"],"prefix":"10.1007","volume":"53","author":[{"given":"Matteo","family":"Monami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benedetta","family":"Ragghianti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Zannoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Vitale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Besmir","family":"Nreu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edoardo","family":"Mannucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,3,26]]},"reference":[{"key":"732_CR1","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.2337\/dc12-0413","volume":"35","author":"SE Inzucchi","year":"2012","unstructured":"Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, Peters AL, Tsapas A, Wender R, Matthews DR (2012) Management of hyperglycemia in type 2 diabetes: a patient-centered approach. Position statement of the American diabetes association (ADA) and the European association for the study of diabetes (EASD). Diabetes Care 35:1364\u20131379","journal-title":"Diabetes Care"},{"key":"732_CR2","author":"P Rys","year":"2015","unstructured":"Rys P, Wojciechowski P, Rogoz-Sitek A, Niesyczy\u0144ski G, Lis J, Syta A, Malecki MT (2015) Systematic review and meta-analysis of randomized clinical trials comparing efficacy and safety outcomes of insulin glargine with NPH insulin, premixed insulin preparations or with insulin detemir in type 2 diabetes mellitus. Acta Diabetol. doi: 10.1007\/s00592-014-0698-4","journal-title":"Acta Diabetol"},{"key":"732_CR3","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.diabres.2008.04.007","volume":"81","author":"M Monami","year":"2008","unstructured":"Monami M, Marchionni N, Mannucci E (2008) Long-acting insulin analogues versus NPH human insulin in type 2 diabetes: a meta-analysis. Diabetes Res Clin Pract 81:184\u2013189","journal-title":"Diabetes Res Clin Pract"},{"key":"732_CR4","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/s00592-014-0663-2","volume":"51","author":"SC Kim","year":"2014","unstructured":"Kim SC, Glynn RJ, Liu J, Everett BM, Goldfine AB (2014) Dipeptidyl peptidase-4 inhibitors do not increase the risk of cardiovascular events in type 2 diabetes: a cohort study. Acta Diabetol 51:1015\u20131023","journal-title":"Acta Diabetol"},{"key":"732_CR5","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/dom.12000","volume":"15","author":"M Monami","year":"2013","unstructured":"Monami M, Ahr\u00e9n B, Dicembrini I, Mannucci E (2013) Dipeptidyl peptidase-4 inhibitors and cardiovascular risk: a meta-analysis of randomized clinical trials. Diabetes Obes Metab 15:112\u2013120","journal-title":"Diabetes Obes Metab"},{"key":"732_CR6","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa1307684","volume":"369","author":"BM Scirica","year":"2013","unstructured":"Scirica BM, Bhatt DL, Braunwald E, Steg PG, Davidson J, Hirshberg B, Ohman P, Frederich R, Wiviott SD, Hoffman EB, Cavender MA, Udell JA, Desai NR, Mosenzon O, McGuire DK, Ray KK, Leiter LA, Raz I (2013) SAVOR-TIMI 53 steering committee and investigators. Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus. N Engl J Med 369:1317\u20131326","journal-title":"N Engl J Med"},{"key":"732_CR7","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1056\/NEJMoa1305889","volume":"369","author":"WB White","year":"2013","unstructured":"White WB, Cannon CP, Heller SR, Nissen SE, Bergenstal RM, Bakris GL, Perez AT, Fleck PR, Mehta CR, Kupfer S, Wilson C, Cushman WC, Zannad F (2013) EXAMINE investigators. Alogliptin after acute coronary syndrome in patients with type 2 diabetes. N Engl J Med 369:1327\u20131335","journal-title":"N Engl J Med"},{"key":"732_CR8","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/0895-4356(94)90129-5","volume":"47","author":"M Charlson","year":"1994","unstructured":"Charlson M, Szatrowski T, Peterson T, Gold J (1994) Validation of a combined comorbidity index. J Clin Epidemiol 47:1245\u20131251","journal-title":"J Clin Epidemiol"},{"key":"732_CR9","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/1741-7015-11-141","volume":"11","author":"LM Brewster","year":"2013","unstructured":"Brewster LM, Seedat YK (2013) Why do hypertensive patients of African ancestry respond better to calcium blockers and diuretics than to ACE inhibitors and \u03b2-adrenergic blockers? A systematic review. BMC Med 11:141","journal-title":"BMC Med"},{"key":"732_CR10","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/bcp.12056","volume":"76","author":"S Kasichayanula","year":"2013","unstructured":"Kasichayanula S, Liu X, Pe Benito M, Yao M, Pfister M, LaCreta FP, Humphreys WG, Boulton DW (2013) The influence of kidney function on dapagliflozin exposure, metabolism and pharmacodynamics in healthy subjects and in patients with type 2 diabetes mellitus. Br J Clin Pharmacol 76:432\u2013444","journal-title":"Br J Clin Pharmacol"},{"key":"732_CR11","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s12020-013-0090-0","volume":"46","author":"K Esposito","year":"2014","unstructured":"Esposito K, Chiodini P, Capuano A et al (2014) Baseline glycemic parameters predict the hemoglobin A1c response to DPP-4 inhibitors : meta-regression analysis of 78 randomized controlled trials with 20,053 patients. Endocrine 46:43\u201351","journal-title":"Endocrine"},{"key":"732_CR12","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1365-2265.2011.04240.x","volume":"77","author":"S Lim","year":"2012","unstructured":"Lim S, An JH, Shin H, Khang AR, Lee Y, Ahn HY, Yoon JW, Kang SM, Choi SH, Cho YM, Park KS, Jang HC (2012) Factors predicting therapeutic efficacy of combination treatment with sitagliptin and metformin in type 2 diabetic patients: the COSMETIC study. Clin Endocrinol (Oxf) 77:215\u2013223","journal-title":"Clin Endocrinol (Oxf)"},{"key":"732_CR13","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/dmrr.1184","volume":"27","author":"M Monami","year":"2011","unstructured":"Monami M, Cremasco F, Lamanna C, Marchionni N, Mannucci E (2011) Predictors of response to dipeptidyl peptidase-4 inhibitors: evidence from randomized clinical trials. Diabetes Metab Res Rev 27:362\u2013372","journal-title":"Diabetes Metab Res Rev"},{"key":"732_CR14","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","volume":"352","author":"UK Prospective Diabetes Study (UKPDS) Group","year":"1998","unstructured":"UK Prospective Diabetes Study (UKPDS) Group (1998) Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352:854\u2013865","journal-title":"Lancet"},{"key":"732_CR15","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jtcvs.2010.09.064","volume":"142","author":"SC Stamou","year":"2011","unstructured":"Stamou SC, Nussbaum M, Carew JD, Dunn K, Skipper E, Robicsek F, Lobdell KW (2011) Hypoglycemia with intensive insulin therapy after cardiac surgery: predisposing factors and association with mortality. J Thorac Cardiovasc Surg 142:166\u2013173","journal-title":"J Thorac Cardiovasc Surg"}],"container-title":["Acta Diabetologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-015-0732-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00592-015-0732-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-015-0732-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T14:00:41Z","timestamp":1559138441000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00592-015-0732-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,26]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["732"],"URL":"https:\/\/doi.org\/10.1007\/s00592-015-0732-1","relation":{},"ISSN":["0940-5429","1432-5233"],"issn-type":[{"value":"0940-5429","type":"print"},{"value":"1432-5233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,26]]}}}